Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanhuang Runtong Pian
- Development stage
- Phase 3
- Lead developer
- Hunan Academy of Chinese Medicine
- Administration
- Oral
01
Overview
Xuanhuang Runtong Pian is a Traditional Chinese Medicine (TCM) tablet developed by the Hunan Academy of Chinese Medicine for the treatment of constipation associated with yin deficiency. In TCM theory, yin deficiency leads to a lack of moisture in the large intestine, resulting in dry stools and difficult defecation. The formulation is designed to nourish yin and moisten the intestines to facilitate bowel movements. It is currently being evaluated in a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial in China to confirm its safety and therapeutic efficacy over a 4-week treatment course.
- Brand names
- Xuanhuang Runtong Pian
- Other names
- 玄黄润通片
Beyond the preview
Go deeper on Xuanhuang Runtong Pian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuanhuang Runtong Pian.